KOREA PHARMA Co., Ltd. (KOSDAQ:032300)
South Korea flag South Korea · Delayed Price · Currency is KRW
11,620
+520 (4.68%)
At close: Apr 1, 2026

KOREA PHARMA Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
126,736141,787166,982257,943233,403529,520
Market Cap Growth
-27.01%-15.09%-35.26%10.51%-55.92%118.69%
Enterprise Value
138,143146,597151,067248,815222,946528,191
Last Close Price
11620.0013000.0015251.2123482.1421200.5747987.24
PE Ratio
--44.043079.40-83.15
Forward PE
-82.1082.1082.1082.10112.13
PS Ratio
1.451.622.053.102.886.65
PB Ratio
1.842.062.343.763.909.21
P/TBV Ratio
1.942.172.483.964.109.72
P/FCF Ratio
--34.8178.4440.14114.12
P/OCF Ratio
47.1752.7820.7553.5228.1973.62
EV/Sales Ratio
1.581.671.862.992.756.64
EV/EBITDA Ratio
69.0264.3117.0128.7526.0271.46
EV/EBIT Ratio
--24.8242.6036.03105.34
EV/FCF Ratio
-8.15-31.4975.6738.34113.83
Debt / Equity Ratio
0.570.570.320.510.910.94
Debt / EBITDA Ratio
17.0817.082.584.036.387.27
Debt / FCF Ratio
--4.7710.609.4011.58
Net Debt / Equity Ratio
0.170.17-0.21-0.20-0.14-0.15
Net Debt / EBITDA Ratio
5.005.00-1.66-1.55-0.99-1.19
Net Debt / FCF Ratio
-0.67-0.67-3.08-4.09-1.45-1.90
Asset Turnover
0.730.730.700.660.620.76
Inventory Turnover
2.742.742.462.592.672.40
Quick Ratio
0.740.742.761.891.143.13
Current Ratio
1.141.143.812.561.413.81
Return on Equity (ROE)
-3.77%-3.77%5.42%0.13%-1.91%12.25%
Return on Assets (ROA)
-0.46%-0.46%3.26%2.89%2.97%2.97%
Return on Invested Capital (ROIC)
-1.14%-1.30%10.57%0.46%12.37%11.11%
Return on Capital Employed (ROCE)
-1.30%-1.30%6.50%6.60%10.10%4.80%
Earnings Yield
-2.08%-1.86%2.27%0.03%-0.48%1.20%
FCF Yield
-13.38%-11.96%2.87%1.27%2.49%0.88%
Payout Ratio
--14.38%651.04%-8.56%
Buyback Yield / Dilution
-0.14%-0.14%9.83%-11.22%1.22%-12.80%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.